Syra Health Corp. Class A ( (SYRA) ) has released its Q3 earnings. Here is a breakdown of the information Syra Health Corp. Class A presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Syra Health Corp. is a healthcare solutions company that focuses on prevention, accessibility, and affordability, offering innovative solutions to both public and private healthcare organizations. In its latest earnings report, Syra Health announced a revenue of $1.7 million for the third quarter of 2025, with notable growth in its Population Health segment, which saw a 96% increase year-over-year. The company also reported an improvement in gross margin by 300 basis points to 33% and a significant reduction in net loss by 46% compared to the previous year.
Key financial highlights include the successful upselling of solutions to state health departments and private sector clients, contributing to the robust growth in the Population Health business unit. Despite a decline in overall revenue due to federal spending cuts, Syra Health managed to enhance its operational efficiency, resulting in a decrease in operating expenses by 28% and an improvement in adjusted EBITDA. Additionally, the company achieved a milestone with its SyraBot, a HIPAA and ADA-compliant chatbot, now operational with a managed care organization serving 400,000 members.
The company’s strategic focus on higher-margin business units and cost management efforts, such as a 12% reduction in SG&A expenses and a 43% decrease in salaries and benefits, have positioned it towards a leaner and more efficient operation. Syra Health’s ongoing strategy refinement and targeted marketing initiatives continue to expand its sales pipeline, particularly in the Population Health solutions portfolio.
Looking ahead, Syra Health’s management remains optimistic about capitalizing on market momentum and maintaining cost discipline to move steadily towards profitability. The company is well-positioned to leverage its market demand and strategic initiatives as federal budget clarity improves.